← Back to Clinical Trials
Recruiting NCT06556888
NCT06556888 Observatory of Immunological Thrombopenic Purpura in the Brest Region
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06556888 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Brest |
| Condition | Immune Thrombocytopenia |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2019-06-20 |
| Primary Completion | 2020-11-19 |
Trial Parameters
Condition Immune Thrombocytopenia
Sponsor University Hospital, Brest
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2019-06-20
Completion 2020-11-19
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Database of patients with ITP, diagnosed, treated and followed in the Brest University Hospital.
Eligibility Criteria
Inclusion Criteria: * Patients with ITP agree to participate Exclusion Criteria: * Other thrombocythopenia other than ITP * Patients Under guardianship * Patients without national social security
Related Trials
NCT04005638
Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopeni
View Trial →
NCT06715215
Role of Acute Phase Proteins In Diagnosis of Immune Thrombocytopenia
View Trial →
NCT06556888
Observatory of Immunological Thrombopenic Purpura in the Brest Region
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology